Grants per year
Personal profile
Certifications and Licenses
Medical Oncology | |
Hematology | |
Internal Medicine |
Training Experience
2004 | Residency, University of Chicago Hospitals |
2007 | Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
Education/Academic qualification
MD, University of Pittsburgh
… → 2001
Research interests
- Acute Leukemias
- Anemia
- Aplastic Anemia
- Chronic Leukemias
- Leukemia
- Myelodysplastic Syndrome
- Myeloproliferative Diseases
- Targeted Therapies
Fingerprint
Dive into the research topics where Jessica K Altman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 18 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants
-
Prot #PrE0905: Randomized Trial of Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia (AML)
Alpha Oncology, Inc., PrECOG, LLC
1/30/20 → 1/30/23
Project: Research project
Research Output
-
American society of hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults
Sekeres, M. A., Guyatt, G., Abel, G., Alibhai, S., Altman, J. K., Buckstein, R., Choe, H., Desai, P., Erba, H., Hourigan, C. S., LeBlanc, T. W., Litzow, M., MacEachern, J., Michaelis, L. C., Mukherjee, S., O'Dwyer, K., Rosko, A., Stone, R., Agarwal, A., Colunga-Lozano, L. E. & 3 others, , Aug 11 2020, In: Blood Advances. 4, 15, p. 3528-3549 22 p.Research output: Contribution to journal › Review article › peer-review
Open Access3 Scopus citations -
Chronic myeloid leukemia, version 2.2021
Deininger, M. W., Shah, N. P., Altman, J. K., Berman, E., Bhatia, R., Bhatnagar, B., DeAngelo, D. J., Gotlib, J., Hobbs, G., Maness, L., Mead, M., Metheny, L., Mohan, S., Moore, J. O., Naqvi, K., Oehler, V., Pallera, A. M., Patnaik, M., Pratz, K., Pusic, I. & 9 others, , Oct 2020, In: JNCCN Journal of the National Comprehensive Cancer Network. 18, 10, p. 1385-1415 31 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
COVID-19 and Cancer Consortium, Jun 20 2020, In: The Lancet. 395, 10241, p. 1907-1918 12 p.Research output: Contribution to journal › Article › peer-review
215 Scopus citations -
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia
Roboz, G. J., DiNardo, C. D., Stein, E. M., de Botton, S., Mims, A. S., Prince, G. T., Altman, J. K., Arellano, M. L., Donnellan, W., Erba, H. P., Mannis, G. N., Pollyea, D. A., Stein, A. S., Uy, G. L., Watts, J. M., Fathi, A. T., Kantarjian, H. M., Tallman, M. S., Choe, S., Dai, D. & 11 others, , Feb 13 2020, In: Blood. 135, 7, p. 463-471 9 p.Research output: Contribution to journal › Review article › peer-review
Open Access30 Scopus citations -
Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML
Choe, S., Wang, H., DiNardo, C. D., Stein, E. M., de Botton, S., Roboz, G. J., Altman, J. K., Mims, A. S., Watts, J. M., Pollyea, D. A., Fathi, A. T., Tallman, M. S., Kantarjian, H. M., Stone, R. M., Quek, L., Konteatis, Z., Dang, L., Nicolay, B., Nejad, P., Liu, G. & 9 others, , May 12 2020, In: Blood Advances. 4, 9, p. 1894-1905 12 p.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations